Anti-inflammatory drugs use impacts the risk of developing PD in LRRK2 mutation carriers | 2020 | September

Share:

MDS Podcast

Science


Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort.